Literature DB >> 53460

Letter: Subacute and chronic active hepatitis after withdrawal of chemotherapy.

J R Wands.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 53460     DOI： 10.1016/s0140-6736(75)90391-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Reactivation of precore mutant hepatitis B virus leading to fulminant hepatic failure following cytotoxic treatment.

Authors:  M Yoshiba; K Sekiyama; F Sugata; H Okamoto; K Yamamoto; S Yotsumoto
Journal:  Dig Dis Sci       Date:  1992-08       Impact factor: 3.199

2.  Fulminant hepatitis due to reactivation of chronic hepatitis B virus infection after allogeneic bone marrow transplantation.

Authors:  E A Pariente; A Goudeau; F Dubois; C Degott; E Gluckman; A Devergie; C Brechot; C Schenmetzler; J Bernuau
Journal:  Dig Dis Sci       Date:  1988-09       Impact factor: 3.199

3.  Fulminant hepatic failure in nephrotic syndrome related to withdrawal of immunosuppressive therapy.

Authors:  J K Onwubalili
Journal:  Postgrad Med J       Date:  1988-04       Impact factor: 2.401

Review 4.  Dangers of immunosuppressive therapy in hepatitis B virus carriers.

Authors:  E Lueg; J Heathcote
Journal:  CMAJ       Date:  1992-10-15       Impact factor: 8.262

5.  Reactivation of hepatitis B virus infection with cytotoxic therapy in non-Hodgkin's lymphoma.

Authors:  M Ozguroglu; A Bilici; H Turna; S Serdengecti
Journal:  Med Oncol       Date:  2004       Impact factor: 3.064

Review 6.  Drug administration in chronic liver disease.

Authors:  J F Westphal; J M Brogard
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.228

Review 7.  Management of Hepatitis B Virus in Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Yibo Wu; He Huang; Yi Luo
Journal:  Front Immunol       Date:  2021-02-04       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.